AcuCort AB Statistics
Total Valuation
AcuCort AB has a market cap or net worth of SEK 88.66 million. The enterprise value is 80.69 million.
Market Cap | 88.66M |
Enterprise Value | 80.69M |
Important Dates
The next estimated earnings date is Friday, February 14, 2025.
Earnings Date | Feb 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AcuCort AB has 119.17 million shares outstanding. The number of shares has increased by 219.67% in one year.
Current Share Class | n/a |
Shares Outstanding | 119.17M |
Shares Change (YoY) | +219.67% |
Shares Change (QoQ) | +63.29% |
Owned by Insiders (%) | 0.34% |
Owned by Institutions (%) | n/a |
Float | 118.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 10.66 |
PB Ratio | 1.82 |
P/TBV Ratio | 2.03 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -5.68 |
EV / Sales | 11.51 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.74
Current Ratio | 3.74 |
Quick Ratio | 3.48 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -19.39 |
Financial Efficiency
Return on equity (ROE) is -33.66% and return on invested capital (ROIC) is -20.38%.
Return on Equity (ROE) | -33.66% |
Return on Assets (ROA) | -18.10% |
Return on Capital (ROIC) | -20.38% |
Revenue Per Employee | 2.34M |
Profits Per Employee | -4.74M |
Employee Count | 3 |
Asset Turnover | 0.15 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +90.84% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +90.84% |
50-Day Moving Average | 0.82 |
200-Day Moving Average | 0.81 |
Relative Strength Index (RSI) | 48.65 |
Average Volume (20 Days) | 640,090 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AcuCort AB had revenue of SEK 7.01 million and -14.21 million in losses. Loss per share was -0.14.
Revenue | 7.01M |
Gross Profit | -8.53M |
Operating Income | -13.77M |
Pretax Income | -14.21M |
Net Income | -14.21M |
EBITDA | n/a |
EBIT | -13.77M |
Loss Per Share | -0.14 |
Balance Sheet
Cash & Cash Equivalents | 7.98M |
Total Debt | n/a |
Net Cash | 7.98M |
Net Cash Per Share | 0.07 |
Equity (Book Value) | 48.73M |
Book Value Per Share | 0.41 |
Working Capital | 7.04M |
Cash Flow
Operating Cash Flow | -19.94M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is -121.67%, with operating and profit margins of -196.33% and -202.70%.
Gross Margin | -121.67% |
Operating Margin | -196.33% |
Pretax Margin | -202.70% |
Profit Margin | -202.70% |
EBITDA Margin | n/a |
EBIT Margin | -196.33% |
FCF Margin | n/a |
Dividends & Yields
AcuCort AB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -219.67% |
Shareholder Yield | -219.67% |
Earnings Yield | -19.01% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AcuCort AB has an Altman Z-Score of 11.35.
Altman Z-Score | 11.35 |
Piotroski F-Score | n/a |